EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Update and reuse: Structure-guided nanobody evolution against SARS-CoV-2 escape

Fan Bu, Divyasha Saxena, Hailey Turner-Hubbard, Amy Delaney, Lalit Batra, Charlie Fricke, Skyler Moye, Abhishek Verma, Stanley Perlman, Janarjan Bhandari, Bin Liu, Gang Ye und 2 weitere

PLOS Pathogens · 18.05.2026 · 22 (5) · e1014223

DOI: 10.1371/journal.ppat.1014223 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 18.05.2026. Verfasst von Fan Bu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota, United States of America. Hauptthemen laut MEDLINE: Single-Domain Antibodies, SARS-CoV-2, Spike Glycoprotein, Coronavirus, Antibodies, Viral. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SARS-CoV-2 continues to accumulate spike mutations that erode the efficacy of antibody therapeutics. The Q493E mutation in the spike RBD, present in recent Omicron subvariants, enables escape from many antibodies and nanobodies, including our Nanosota-9A nanobody, which neutralizes Omicron JN.1 (Q493) but not KP.3 (E493). To address this, we applied a structure-guided in vitro evolution strategy to engineer Nanosota-9A, generating Nanosota-9B, which binds the KP.3 RBD with high affinity but shows reduced binding to JN.1 RBD. To regain breadth, we engineered a bispecific nanobody combining Nanosota-9A and -9B, which effectively neutralizes both JN.1 and KP.3 in infection assays. Our results provide proof of concept for an “update and reuse” strategy: applying structure-guided engineering to update and reuse validated nanobodies to overcome variant escape. This strategy offers a practical path to maintain therapeutic coverage as the virus evolves, supporting more efficient use of research resources and faster responses to emerging variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Single-Domain AntibodiesSARS-CoV-2Spike Glycoprotein, CoronavirusAntibodies, ViralAntibodies, NeutralizingCOVID-19HumansMutationAnimalsDirected Molecular Evolution

Substanzen

Single-Domain AntibodiesSpike Glycoprotein, CoronavirusAntibodies, Viralspike protein, SARS-CoV-2Antibodies, Neutralizing

Autor:innen und Institutionen

  • Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota, United States of America.
  • Center for Emerging Viruses, University of Minnesota, Minneapolis, Minnesota, United States of America.
  • Center for Predictive Medicine, University of Louisville, Kentucky, United States of America.
  • Department of Microbiology and Immunology, University of Iowa, Iowa City, Iowa, United States of America.
  • Hormel Institute, University of Minnesota, Austin, Minnesota, United States of America.
  • Department of Microbiology and Immunology, University of Louisville, Kentucky, United States of America.

ORCID-Profile: Fang Li

Förderung

  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Bu, F., Saxena, D., Turner-Hubbard, H., Delaney, A., Batra, L., Fricke, C., Moye, S., Verma, A., Perlman, S., Bhandari, J., Liu, B., Ye, G., Zheng, J., & Li, F. (2026). Update and reuse: Structure-guided nanobody evolution against SARS-CoV-2 escape. PLOS Pathogens, 22(5), e1014223. https://doi.org/10.1371/journal.ppat.1014223

Vancouver

Bu F, Saxena D, Turner-Hubbard H, Delaney A, Batra L, Fricke C, et al. Update and reuse: Structure-guided nanobody evolution against SARS-CoV-2 escape. PLOS Pathogens. 2026;22(5):e1014223. doi:10.1371/journal.ppat.1014223

BibTeX
@article{Bu2026,
  author = {Bu, Fan and Saxena, Divyasha and Turner-Hubbard, Hailey and Delaney, Amy and Batra, Lalit and Fricke, Charlie and Moye, Skyler and Verma, Abhishek and Perlman, Stanley and Bhandari, Janarjan and Liu, Bin and Ye, Gang and Zheng, Jian and Li, Fang},
  title = {Update and reuse: Structure-guided nanobody evolution against SARS-CoV-2 escape},
  journal = {PLOS Pathogens},
  year = {2026},
  volume = {22},
  number = {5},
  pages = {e1014223},
  doi = {10.1371/journal.ppat.1014223}
}
Kostenlos starten →